Molecular Detection of Neglected Tropical Diseases: The Case for Automated Near-Point-of-Care Diagnosis of Leishmaniasis.

Gow, I; Smith, N; Stark, D; Ellis, J

Molecular Detection of Neglected Tropical Diseases: The Case for Automated Near-Point-of-Care Diagnosis of Leishmaniasis.

Gow, I Smith, N Stark, D Ellis, J

Permalink

Publisher:: American Society of Tropical Medicine and Hygiene
Publication Type:: Journal Article
Citation:: Am J Trop Med Hyg, 2023, 108, (1), pp. 2-6
Issue Date:: 2023-01-11

Open Access

Copyright Clearance Process

Recently Added
In Progress
Open Access

This item is open access.

The embargo period expires on 11 Jan 2024

Adobe PDF

Download full textAdobe PDF (663.08 kB)

View on publisher's site

View statistics

Full metadata record

Field	Value	Language
dc.contributor.author	Gow, I
dc.contributor.author	Smith, N
dc.contributor.author	Stark, D
dc.contributor.author	Ellis, J https://orcid.org/0000-0001-7328-4831
dc.date.accessioned	2023-03-13T06:37:12Z
dc.date.available	2022-08-13
dc.date.available	2023-03-13T06:37:12Z
dc.date.issued	2023-01-11
dc.identifier.citation	Am J Trop Med Hyg, 2023, 108, (1), pp. 2-6
dc.identifier.issn	0002-9637
dc.identifier.issn	1476-1645
dc.identifier.uri	http://hdl.handle.net/10453/167153
dc.description.abstract	Neglected tropical diseases affect those in poorer nations disproportionately across the globe. One example of these, leishmaniasis, is a debilitating and potentially fatal parasitic infection. Molecular detection of this disease can provide accurate and fast diagnosis, and with near point-of-care technologies, detection can be provided in many health-care settings. Traditionally, the perceived limitations to such detection methods have hindered their provision to resource-limited nations, but new technologies and techniques are helping to overcome these perceptions. The current pandemic offers an opportunity to maintain and develop further advances, ensuring molecular diagnostics are accessible to all.
dc.format	Electronic-Print
dc.language	eng
dc.publisher	American Society of Tropical Medicine and Hygiene
dc.relation	St Vincent's Hospital Sydney Limited
dc.relation.ispartof	Am J Trop Med Hyg
dc.relation.isbasedon	10.4269/ajtmh.22-0373
dc.rights	info:eu-repo/semantics/embargoedAccess
dc.subject	11 Medical and Health Sciences
dc.subject.classification	Tropical Medicine
dc.subject.mesh	Humans
dc.subject.mesh	Point-of-Care Systems
dc.subject.mesh	Leishmaniasis
dc.subject.mesh	Parasitic Diseases
dc.subject.mesh	Neglected Diseases
dc.subject.mesh	Humans
dc.subject.mesh	Parasitic Diseases
dc.subject.mesh	Leishmaniasis
dc.subject.mesh	Point-of-Care Systems
dc.subject.mesh	Neglected Diseases
dc.subject.mesh	Humans
dc.subject.mesh	Point-of-Care Systems
dc.subject.mesh	Leishmaniasis
dc.subject.mesh	Parasitic Diseases
dc.subject.mesh	Neglected Diseases
dc.title	Molecular Detection of Neglected Tropical Diseases: The Case for Automated Near-Point-of-Care Diagnosis of Leishmaniasis.
dc.type	Journal Article
utslib.citation.volume	108
utslib.location.activity	United States
utslib.for	11 Medical and Health Sciences
pubs.organisational-group	/University of Technology Sydney
pubs.organisational-group	/University of Technology Sydney/Faculty of Science
pubs.organisational-group	/University of Technology Sydney/Faculty of Science/School of Life Sciences
utslib.copyright.status	open_access	*
utslib.copyright.embargo	2024-01-11T00:00:00+1000Z
dc.date.updated	2023-03-13T06:37:10Z
pubs.issue	1
pubs.publication-status	Published online
pubs.volume	108
utslib.citation.issue	1

Abstract:

Neglected tropical diseases affect those in poorer nations disproportionately across the globe. One example of these, leishmaniasis, is a debilitating and potentially fatal parasitic infection. Molecular detection of this disease can provide accurate and fast diagnosis, and with near point-of-care technologies, detection can be provided in many health-care settings. Traditionally, the perceived limitations to such detection methods have hindered their provision to resource-limited nations, but new technologies and techniques are helping to overcome these perceptions. The current pandemic offers an opportunity to maintain and develop further advances, ensuring molecular diagnostics are accessible to all.

Please use this identifier to cite or link to this item:

http://hdl.handle.net/10453/167153